Zantac, Ranitidine Pulled From Market, Here Are FDA’s Latest Cancer Concerns New findings about N-Nitrosodimethylamine (NDMA) contamination of this type of heartburn medication led to the U.S. Food and Drug Administration's (FDA's) more drastic action.